Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P)

scientific article

Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P) is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1052142168
P356DOI10.1186/1471-2407-9-295
P932PMC publication ID2739225
P698PubMed publication ID19698163
P5875ResearchGate publication ID26758573

P50authorMurray KrahnQ41896189
Alexander KatalinicQ55241176
P2093author name stringVolker Rohde
Annika Waldmann
Karen Bremner
Thomas Kuechler
P2860cites workA new method of classifying prognostic comorbidity in longitudinal studies: development and validationQ29547376
Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German populationQ30655427
Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancerQ33845220
Sexual dysfunction after radical prostatectomy: prevalence, treatments, restricted use of treatments and distressQ36310552
Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratificationQ37074954
Prevalence of erectile dysfunction among middle-aged men in a metropolitan area in GermanyQ39764379
The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30.Q41306600
Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancerQ44017845
The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancerQ46446945
Disease-specific symptoms and general quality of life of patients with prostate carcinoma before and after primary three-dimensional conformal radiotherapyQ47367499
Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapyQ48753915
Socioeconomic disparities in psychosocial wellbeing in cancer patientsQ50084134
Marker states and a health state prompt provide modest improvements in the reliability and validity of the standard gamble and rating scale in prostate cancer patients.Q51904709
Responsiveness of disease-specific and generic utility instruments in prostate cancer patients.Q51910336
Reliability and validity of the PORPUS, a combined psychometric and utility-based quality-of-life instrument for prostate cancer.Q53300048
Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer.Q53303164
Construction of the Patient-Oriented Prostate Utility Scale (PORPUS): a multiattribute health state classification system for prostate cancer.Q53511896
Interpreting the significance of changes in health-related quality-of-life scores.Q53584979
Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer.Q53585349
Interpreting clinically significant changes in patient-reported outcomesQ58876704
NIH Consensus Conference. Impotence. NIH Consensus Development Panel on ImpotenceQ70758303
Urinary incontinence in both sexes: prevalence rates and impact on quality of life and sexual lifeQ73748049
Relation between severe illness and non-completion of quality-of-life questionnaires by patients with rectal cancerQ73885791
Prostate-specific symptoms of prostate cancer in a German general populationQ79355851
Prostate operations: long-term effects on sexual and urinary function and quality of life. Comparison with an age-matched control populationQ79853190
Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomyQ80744531
P407language of work or nameEnglishQ1860
P921main subjectCanadaQ16
GermanyQ183
adaptive radiation therapyQ180507
quality of lifeQ13100823
P304page(s)295
P577publication date2009-08-23
P1433published inBMC CancerQ326300
P1476titleMeasuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P)
P478volume9

Reverse relations

cites work (P2860)
Q34136485Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments
Q37132768Different aspects of self-reported quality of life in 450 german melanoma survivors
Q82646146Fatigue in hormone-naïve prostate cancer patients treated with radical prostatectomy or definitive radiotherapy
Q42176848Measuring quality of life after radical prostatectomy from the patient's perspective
Q38079169Measuring symptoms in localized prostate cancer: a systematic review of assessment instruments
Q36852329Oncology Section EDGE Task Force on Prostate Cancer: A Systematic Review of Outcome Measures for Health-Related Quality of Life
Q34500415Predictors of the trajectories of self-reported sleep disturbance in men with prostate cancer during and following radiation therapy
Q30641961The ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study
Q85719845[Prostate cancer in routine healthcare: health-related quality of life after inpatient treatment]
Q83326729[Temporal changes in quality of life after prostate carcinoma]

Search more.